<DOC>
	<DOCNO>NCT01420666</DOCNO>
	<brief_summary>The purpose study determine whether analgesic effect Maxigesic USA great acetaminophen , ibuprofen placebo patient painful osteoarthritis hip knee .</brief_summary>
	<brief_title>Maxi-Analgesic Osteoarthritis ( OA ) Study</brief_title>
	<detailed_description>Osteoarthritis significant disable disease develop world . Published guideline medical management osteoarthritis expert group , general advocate acetaminophen first line treatment . The European League Against Rheumatism ( EULAR ) guideline ( 1 ) recommend acetaminophen first choice therapy OA , NSAIDs reserve patient unresponsive acetaminophen . The American College Rheumatology Guidelines ( 2 ) recommend acetaminophen consider reasonable initial therapy patient mild moderate OA pain NSAIDs consider initial alternative moderate severe OA pain . The Canadian guideline recommend acetaminophen mild OA pain NSAIDs moderate severe OA ( 3 ) . A Cochrane Review acetaminophen osteoarthritis conclude NSAIDs superior acetaminophen improve knee hip pain people OA . However , note size treatment effect modest NSAIDs appear effective OA subject moderate-to-severe pain ( 4 ) . There many situation clinical practice either acetaminophen alone low dose ibuprofen sufficiently effective . In case dose acetaminophen increase 4000mg/day due toxicity concern . In case ibuprofen dose increase 1200mg/day 2400mg/day . However comparison low dose ibuprofen high dose show gastrointestinal ( GI ) toxicity increase : relative risk ( RR ) GI complication increase 1.6 ( 95 % CI 0.8 , 3.2 ) low dose ibuprofen 4.2 ( 95 % CI 1.8 , 9.8 ) high dose ibuprofen ( 5 ) . Ibuprofen associate low risk serious gastrointestinal complication , advantage probably lose dos 1800 mg/day ( 6 ) . A simple combination treatment whereby acetaminophen ibuprofen take together one single tablet time day would , effective , advantage increase analgesia without raise ibuprofen dose 1200mg/day ( 1170mg administer every 6 hour ) lose improve safety profile associate low dose ibuprofen . 1 . Pendleton A , Arden N , Dougados M , Doherty M , Bannwarth B , Bijlsma JW , et al . EULAR recommendation management knee osteoarthritis : report task force Standing Committee International Clinical Studies Including Therapeutic Trials ( ESCISIT ) . Ann Rheum Dis . 2000 ; 59 ( 12 ) :936-44 . 2 . Recommendations medical management osteoarthritis hip knee : 2000 update . American College Rheumatology Subcommittee Osteoarthritis Guidelines . Arthritis Rheum . 2000 ; 43 ( 9 ) :1905-15 . 3 . Tannenbaum H , Peloso PM , Russell AS , Marlow B . An evidence-based approach prescribe NSAIDs treatment osteoarthritis rheumatoid arthritis : The Second Canadian Consensus Conference . Can J Clin Pharmacol . 2000 ; 7 Suppl A:4A-16A . 4 . Towheed TE , Maxwell L , Judd MG , Catton M , Hochberg MC , Wells G. Acetaminophen osteoarthritis . Cochrane Database Syst Rev . 2006 ( 1 ) : CD004257 . 5 . Henry D , Lim LLY , Garcia Rodriguez LA , Perez Gutthann S , Carson JL , Griffin M , et al . Variability risk gastrointestinal complication individual non-steroidal anti-inflammatory drug : Results collaborative meta-analysis . British Medical Journal . 1996 ; 312 ( 7046 ) :1563-6 . 6 . Henry D , McGettigan P. Epidemiology overview gastrointestinal renal toxicity NSAIDs . Int J Clin Pract Suppl . 2003 ; Supplement . ( 135 ) :43-9 .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Provides write informed consent initiation studyrelated procedure . Have symptom OA knee hip least 6 month require analgesic medication . Have confirm radiological evidence OA . Be 45 80 year age inclusive , day consent . In opinion physician , require long term medication treatment painful OA . Have painful OA knee hip pain score least 40 mm 80 mm WOMAC VAS pain scale rest follow 3 7 day washout exist analgesic . Weigh le 50 kg Rheumatoid arthritis inflammatory arthritis . Gout recurrent episode pseudogout . Paget 's disease . Articular fracture . Ochronosis . Acromegaly . Haemochromatosis . Wilson 's Disease . Primary Osteochondromatosis . Heritable disorder ( e.g . hypermobility ) . Have receive take oral parenteral corticosteroid within 2 month intraarticular hyaluronic acid within 9 month . Has take single dose NSAID acetaminophen within 12 hour prior first dose study drug Known pregnant possibly pregnant Women childbearing potential , opinion investigator , use reliable contraception . Alcohol intake excess 14 unit per week female 21 unit per week male . Have history drug abuse . Suffering neurological disorder relate pain perception . In opinion investigator , unable understand visual analogue pain score . Currently , last 30 day , participate clinical trial involve another study drug . Suffering disease condition , opinion investigator , mean would patient best interest participant study . Hypersensitivity aspirin NSAID Hypersensitivity acetaminophen Severe know haemopoietic , renal hepatic disease , immunosuppression History gastric ulceration , indigestion , stomach pain GI bleeding bleed disorder Currently suffer dehydration diarrhoea and/or vomit History severe asthma define previous steroid treatment hospital admission within last 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>